Stay updated on Avadomide and Nivolumab Combo in Adv Melanoma Clinical Trial
Sign up to get notified when there's something new on the Avadomide and Nivolumab Combo in Adv Melanoma Clinical Trial page.

Latest updates to the Avadomide and Nivolumab Combo in Adv Melanoma Clinical Trial page
- Check3 days agoChange DetectedThe study page now displays a 403 Forbidden error, replacing the detailed study record with only a minimal header and a Home link. The core content such as the title, summary, eligibility criteria, and outcomes is no longer accessible.SummaryDifference18%

- Check10 days agoChange DetectedThe page's revision tag was updated from v3.6.6 to v3.7.0, signaling a site update while preserving the displayed study information.SummaryDifference0.1%

- Check17 days agoChange DetectedDeleted the MedlinePlus related topics header and its entries for Melanoma and MedlinePlus Genetics from the page, removing quick-access links to these related topics.SummaryDifference0.2%

- Check24 days agoChange DetectedRevision label updated from v3.6.5 to v3.6.6, indicating a small behind-the-scenes update to the page without changing the visible study details.SummaryDifference0.1%

- Check38 days agoChange DetectedThe page adds Melanoma as a related topic and includes MedlinePlus Genetics as a related topics resource, enriching disease context and linkage to genetics information for readers.SummaryDifference0.2%

- Check45 days agoChange DetectedThe page now shows Revision: v3.6.5 in the footer, and items like Melanoma, related topics:, MedlinePlus Genetics, and Revision: v3.6.4 were removed.SummaryDifference0.2%

Stay in the know with updates to Avadomide and Nivolumab Combo in Adv Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Avadomide and Nivolumab Combo in Adv Melanoma Clinical Trial page.